$SRPT
Sarepta Therapeutics,, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$17.50
▼-0.40%-$0.070
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSarepta Therapeutics,, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SRPT down today? It is at $17.50 (-0.40%), and our scanner flagged it 142 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SRPT spikes, and full due diligence on SRPT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SRPT 142 times in the last 30 days. Create a free account to track $SRPT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SRPT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SRPT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KMaterial AgreementSep 23, 2026 · 11 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Rodino-Klapac Louise Officer | Sold (automatic/other) | -21K 0.02% of company | sold 9.5% | 204K | $476K at $22.22 | Sep 4, 26 |
Rothfuss Cristin Officer | Sold (automatic/other) | -22K 0.02% of company | sold 16% | 116K | $489K at $22.22 | Sep 4, 26 |
Estepan Ian Michael Officer | Sold (automatic/other) | -25K 0.02% of company | sold 12% | 177K | $551K at $22.22 | Sep 4, 26 |
Wong Ryan Ho-Yan Officer | Sold (automatic/other) | -13K 0.01% of company | sold 9.8% | 122K | $295K at $22.22 | Sep 4, 26 |
Severino Michael Officer | Acquired (grant/award) | +756K 0.7% of company | n/a | 756K | n/a | Jul 28, 26 |
Barry Richard Director | Acquired (grant/award) | +17K 0.02% of company | added 0.6% | 2.98M | n/a | Jun 4, 26 |
Chambers Michael Andrew Director | Acquired (grant/award) | +17K 0.02% of company | added 100% | 28K | n/a | Jun 4, 26 |
Nicaise Claude Director | Acquired (grant/award) | +17K 0.02% of company | added 54% | 48K | n/a | Jun 4, 26 |
Connelly Deirdre P Director | Acquired (grant/award) | +17K 0.02% of company | added 100% | 22K | n/a | Jun 4, 26 |
Behrens M Kathleen Director | Acquired (grant/award) | +17K 0.02% of company | added 8.5% | 214K | n/a | Jun 4, 26 |
Wigzell Hans Lennart Rudolf Director | Acquired (grant/award) | +17K 0.02% of company | added 67% | 42K | n/a | Jun 4, 26 |
Mayo Stephen Director | Acquired (grant/award) | +17K 0.02% of company | added 100% | 19K | n/a | Jun 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SRPT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SRPT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SRPT last traded at $17.50, down 0.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Sarepta Therapeutics,, Inc. Common Stock (SRPT) is next expected to report earnings on Monday, November 2, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SRPT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SRPT 142 times in the last 30 days.
SRPT (Sarepta Therapeutics,, Inc. Common Stock) trades on XNAS, with a market cap of about $1.85B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SRPT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SRPT discussion
Sign in to ask a question or join the discussion.